Nautilus Biotechnolgy Ownership | Who Owns Nautilus Biotechnolgy?


OverviewForecastRevenueFinancialsChartTranscripts

Nautilus Biotechnolgy Ownership Summary


Nautilus Biotechnolgy is owned by 39.62% institutional investors, 32.02% insiders, and 28.37% retail investors. Ah capital management is the largest institutional shareholder, holding 13.98% of NAUT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.52% of its assets in Nautilus Biotechnolgy shares.

NAUT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNautilus Biotechnolgy39.62%32.02%28.37%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ah capital management17.65M13.98%$68.50M
Perceptive advisors12.59M9.98%$48.87M
Cercano management7.17M5.68%$27.83M
Madrona venture group6.02M4.77%$5.09M
Blackrock3.83M3.06%$8.96M
Vanguard group2.60M2.06%$5.07M
Clearstead advisors2.33M1.85%$9.04M
Comprehensive financial management2.21M1.75%$8.57M
Millennium management1.27M1.01%$4.94M
Clarius group1.21M0.96%$2.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Madrona venture group6.02M36.76%$5.09M
Ah capital management17.65M5.31%$68.50M
Cercano management7.17M1.20%$27.83M
Perceptive advisors12.59M0.96%$48.87M
Hillman200.00K0.30%$776.00K
Sentinel trust co lba750.00K0.29%$2.91M
Comprehensive financial management2.21M0.28%$8.57M
Clarius group1.21M0.13%$2.36M
Clearstead advisors2.33M0.08%$9.04M
Palumbo wealth management65.23K0.06%$253.10K

Top Buyers

HolderShares% AssetsChange
Clearstead advisors2.33M0.08%2.33M
Vanguard fiduciary trust305.53K0.00%305.53K
Millennium management1.27M0.00%253.39K
Marshall wace, llp319.88K0.00%202.82K
Vanguard group2.60M0.00%166.39K

Top Sellers

HolderShares% AssetsChange
Amazon com---1.46M
Bain capital life sciences investors---1.07M
Tikvah management---726.89K
Archpoint investors---622.41K
Alyeska investment group---253.47K

New Positions

HolderShares% AssetsChangeValue
Clearstead advisors2.33M0.08%2.33M$9.04M
Vanguard fiduciary trust305.53K0.00%305.53K$1.19M
Hrt financial lp65.25K0.00%65.25K$253.00K
Citizens financial group inc/ri50.00K0.00%50.00K$194.00K
Catalyst funds management pty46.33K0.03%46.33K$179.75K

Sold Out

HolderChange
Tower research capital llc (trc)-5.00
Ifp advisors-5.00
Capital performance advisors llp-7.00
True wealth design-17.00
Eversource wealth advisors-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20269517.28%50,268,259-7.49%392.15%6036.36%12-7.69%
Mar 31, 202634-48.48%8,773,885-84.95%60.33%15-48.28%6-57.14%
Dec 31, 202543-33.85%24,012,479-58.53%190.90%1812.50%8-71.43%
Sep 30, 202551-25.00%25,706,577-56.98%200.91%12-65.71%2441.18%
Jun 30, 202568-22.73%59,754,843-4.81%471.88%343.03%18-40.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.93M1.52%-
Vanguard MStar Total Stk Mkt Idx Invest1.93M1.52%-
Vanguard Morn Total Stk Mkt Idx Investor1.93M1.52%-
iShares Russell 2000 ETF1.05M0.82%-18.62K
Vanguard Institutional Extnd Mkt Idx Tr543.26K0.43%-
Fidelity Small Cap Index481.06K0.38%-
iShares Biotechnology ETF420.49K0.33%-
iShares Russell 2000 Value ETF381.23K0.30%-
JPMorgan Small Cap Value I360.90K0.28%360.90K
Russell 2000 Index Non-Lendable Fund315.05K0.25%315.05K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 02, 2026AH Equity Partners Bio II, L.L.C.-Sell$10.85M
Jun 02, 2026AH Equity Partners Bio II, L.L.C.-Sell$902.46K
Mar 04, 2026Patel Sujal M CEO, President, and SecretaryBuy$65.24K
Nov 06, 2025Suzuki Kentaro Chief Marketing OfficerBuy$5.96K
Sep 08, 2025Patel Sujal M CEO, President, and SecretaryBuy$57.03K

Insider Transactions Trends


DateBuySell
2026 Q2-2
2026 Q11-
2025 Q41-
2025 Q33-
2025 Q23-

NAUT Ownership FAQ


Who Owns Nautilus Biotechnolgy?

Nautilus Biotechnolgy shareholders are primarily institutional investors at 39.62%, followed by 32.02% insiders and 28.36% retail investors. The average institutional ownership in Nautilus Biotechnolgy's industry, Biotech Stocks , is 379.61%, which Nautilus Biotechnolgy falls below.

Who owns the most shares of Nautilus Biotechnolgy?

Nautilus Biotechnolgy’s largest shareholders are Ah capital management (17.65M shares, 13.98%), Perceptive advisors (12.59M shares, 9.98%), and Cercano management (7.17M shares, 5.68%). Together, they hold 29.64% of Nautilus Biotechnolgy’s total shares outstanding.

Does Blackrock own Nautilus Biotechnolgy?

Yes, BlackRock owns 3.06% of Nautilus Biotechnolgy, totaling 3.83M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.96M$. In the last quarter, BlackRock increased its holdings by 95.77K shares, a 2.57% change.

Who is Nautilus Biotechnolgy’s biggest shareholder by percentage of total assets invested?

Madrona venture group is Nautilus Biotechnolgy’s biggest shareholder by percentage of total assets invested, with 36.76% of its assets in 6.02M Nautilus Biotechnolgy shares, valued at 5.09M$.

Who is the top mutual fund holder of Nautilus Biotechnolgy shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nautilus Biotechnolgy shares, with 1.52% of its total shares outstanding invested in 1.93M Nautilus Biotechnolgy shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools